Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.05 USD | +0.32% | +0.98% | -34.50% |
Mar. 28 | Arcadia Biosciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Mar. 28 | Transcript : Arcadia Biosciences, Inc., Q4 2023 Earnings Call, Mar 28, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-34.50% | 2.78M | |
+12.96% | 38.79B | |
-.--% | 10.98B | |
-6.41% | 7.52B | |
+3.97% | 6.81B | |
-3.08% | 6B | |
-11.24% | 5.59B | |
+29.81% | 5.26B | |
-13.70% | 4.56B | |
+11.23% | 4.49B |
- Stock Market
- Equities
- RKDA Stock
- News Arcadia Biosciences, Inc.
- Arcadia Biosciences : HC Wainwright Adjusts Arcadia Biosciences' Price Target to $7 From $6, Maintains Buy Rating